gentian violet has been researched along with Malignant Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arbiser, JL; Borgognoni, L; Chiarugi, P; Gagliardi, S; Gerlini, G; Morandi, A; Pietrobono, S; Stecca, B | 1 |
Arbiser, JL; Bips, M; Bonner, MY; Kovach, C; Seidler, A | 1 |
Dooley, TP; Gadwood, RC; Kilgore, K; Thomasco, LM | 1 |
3 other study(ies) available for gentian violet and Malignant Melanoma
Article | Year |
---|---|
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival.
Topics: Apoptosis; Cell Line, Tumor; Cell Self Renewal; Cell Survival; Down-Regulation; G2 Phase Cell Cycle Checkpoints; Gentian Violet; Humans; Melanoma; Mitochondria; Neoplastic Stem Cells; Phosphorylation; Skin Neoplasms; SOXB1 Transcription Factors; STAT3 Transcription Factor | 2016 |
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
Topics: Aged, 80 and over; Aminoquinolines; Anti-Infective Agents, Local; Antineoplastic Agents; Chemoradiotherapy; Drug Therapy, Combination; Gentian Violet; Humans; Imiquimod; Male; Melanoma; Skin Neoplasms | 2012 |
Development of an in vitro primary screen for skin depigmentation and antimelanoma agents.
Topics: Animals; Antineoplastic Agents; Benzene Derivatives; Benzoquinones; Cell Division; Dihydroxyphenylalanine; Drug Screening Assays, Antitumor; Gentian Violet; Melanins; Melanocytes; Melanoma; Mice; Mice, Inbred C57BL; Phenols; Skin; Skin Pigmentation; Tumor Cells, Cultured | 1994 |